Ludhiana, Punjab — In a remarkable blend of academic brilliance and medical innovation, Dr. Suvir Singh, Associate Professor & Head of the Department of Haematology at Dayanand Medical College and Hospital (DMCH), has carved a historic milestone for Punjab by spearheading the state’s first-ever CAR-T Cell Therapy.
Hailing from Ludhiana, Dr. Singh’s journey is a testament to relentless dedication and visionary leadership. Throughout his academic career, he has consistently demonstrated excellence — securing over 15 top honours, including gold and silver medals, university distinctions, and titles such as Best Graduate and Topper in Physiology, Surgery, and Medicine. His list of accolades includes multiple memorial awards that recognize his exceptional contributions to the field of medicine.
Now, Dr. Singh is rewriting the future of cancer treatment by introducing Chimeric Antigen Receptor T-Cell (CAR-T) Therapy at DMCH — a revolutionary immunotherapy that reprograms a patient’s own immune cells to identify and destroy cancer cells with precision. This breakthrough marks a significant advancement not only for Punjab but for India’s expanding medical frontier.
With this pioneering move, Dr. Suvir Singh has transitioned from academic excellence to a mission-driven role that brings transformative care to patients and hope to countless families. His commitment positions DMCH as a center of excellence and innovation in hematological treatments.
This proud moment highlights the potential of Indian medical expertise to lead globally in cancer care. Dr. Singh’s success is a celebration for Ludhiana, Punjab, and the nation at large. 🇮🇳
#MedicalBreakthrough #CARTCellTherapy #DrSuvirSingh #DMCH #CancerCare #PunjabHealthcare #IndiaMedicalInnovation
